| PubChem Compound | 71587624 |
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Atrial Fibrillation | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 2 | Drug ineffective | FAERS: 1 Canada Vigilance: 21 | Canada Vigilance US FAERS | |
| 3 | Dyspepsia | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 4 | Pancytopenia | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 5 | Abdominal Pain | Canada Vigilance: 2 | Canada Vigilance | |
| 6 | Abdominal discomfort | Canada Vigilance: 1 | Canada Vigilance | |
| 7 | Anaphylactic shock | Canada Vigilance: 1 | Canada Vigilance | |
| 8 | Anxiety | Canada Vigilance: 1 | Canada Vigilance | |
| 9 | Arthralgia | Canada Vigilance: 1 | Canada Vigilance | |
| 10 | Burning sensation | Canada Vigilance: 1 | Canada Vigilance | |
| 11 | Constipation | Canada Vigilance: 1 | Canada Vigilance | |
| 12 | Dizziness | Canada Vigilance: 1 | Canada Vigilance | |
| 13 | Eye irritation | Canada Vigilance: 1 | Canada Vigilance | |
| 14 | Headache | Canada Vigilance: 3 | Canada Vigilance | |
| 15 | Nausea | Canada Vigilance: 4 | Canada Vigilance | |
| 16 | Product formulation issue | Canada Vigilance: 1 | Canada Vigilance | |
| 17 | Product substitution issue | Canada Vigilance: 7 | Canada Vigilance | |
| 18 | Therapeutic product effect decreased | Canada Vigilance: 1 | Canada Vigilance | |
| 19 | Therapy non-responder | Canada Vigilance: 3 | Canada Vigilance | |
| 20 | Vomiting | Canada Vigilance: 3 | Canada Vigilance | |
| 21 | treatment failure | Canada Vigilance: 3 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.